This contract expires in 374 days (Sep 22, 2027).

Browse related active opportunities

CAREDX, INC. - GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

PIID: 36C24926N0622
Signed Date: Jul 13, 2026Effective Date: Sep 23, 2026End Date: Closes in 374 days
Award $
$1.0M
Vendor
CAREDX, INC.
NAICS
541380
Signed Date
Jul 13, 2026

Key Details

Dollars Obligated
$1.0M
Base & All Options
$1.0M
Awarding Sub-Agency
Department of Veterans Affairs
Parent IDIQ (PIID)
36C24922D0027
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
NOT COMPETED
Place of Performance
MURFREESBORO, TN

Description

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

Context & Analysis

On Jul 13, 2026, Department of Veterans Affairs obligated $1,049,560.8 to CAREDX, INC. for genetic blood testing for transplant patients (allomap and allosure). The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: not competed. Performance is located in MURFREESBORO, TN. The contract is scheduled through Sep 22, 2027 — approximately 12 months remaining.

Contractor Information

Contractor: CAREDX, INC.
UEI: Y371A27ZEUM4
Location: BRISBANE, CA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related